• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Immunomedics debuts LeukoScan in Europe

Article

Immunomedics of Morris Plains, NJ, last month began shipments to Germany and Austria of LeukoScan, its radiolabeled monoclonal antibody fragment for the detection of infectious disease.Launches in the U.K. and Ireland are expected by the end of May, with

Immunomedics of Morris Plains, NJ, last month began shipments to Germany and Austria of LeukoScan, its radiolabeled monoclonal antibody fragment for the detection of infectious disease.

Launches in the U.K. and Ireland are expected by the end of May, with deliveries to the rest of the European Union countries to follow by the end of August, according to Philippe Barzin, general manager of the company's European subsidiary in Petten, the Netherlands. Barzin will coordinate sales and marketing for LeukoScan in Europe.

Distribution within the European Union will initially be handled by Mallinckrodt's European affiliate, which also partners with Immunomedics to sell and distribute the company's CEA-Scan colorectal cancer imaging agent.

LeukoScan received final clearance from the European Commission in February for sales and marketing in the 15 E.U. nations. The agent is designed for the detection and diagnosis of osteomyelitis involving long bones, particularly in diabetic patients with foot ulcers, according to the company. Immunomedics filed a biologics license application (BLA) for the product with the Food and Drug Administration in December 1996.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.